No Photo Available

Last Update


This profile was last updated on .

Is this you? Claim your profile.

Wrong André Groenewegen?

Dr. André Groenewegen

Non-executive Director, Bio-pharmaceutical Relations

Image Analysis Ltd

HQ Phone: +44 20 7630 9926

Email: a***@***.uk

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Image Analysis Ltd

QABC Minster House 272-274 Vauxhall Bridge Road

London, Greater London SW1V 1BA

United Kingdom

Company Description

We help our clients to utilise MRI and Dynamic Contrast Enhanced (DCE)-MRI in their clinical trials and feasibility studies. MRI and DCE-MRI are of particular value for early detection of inflammatory changes induced by drug candidates with indications ... more

Find other employees at this company (28)

Background Information

Employment History

Senior Vice President, Managing Director Rosemont Pharmaceuticals Ltd. UK

Rosemont Pharmaceuticals Ltd.

Additional Post of Senior Vice President

Bio-Technology General Corp.

Vice President, Head of Health Ecosystem Solutions (HES) Rheumatology



medical degree

State University of Utrecht

Web References (5 Total References)

Team « Image Analysis [cached]

Dr. André Groenewegen - Non-executive Director: Bio-pharmaceutical Relations

With over 20 years of executive strategic, general management, commercial and medical experience in biopharmaceutical industry in the field of Immunology, Oncology, CNS and Female Health Care, Andre has joined IA in 2013 to advice the Board on Global Business Development, Strategy and Marketing.

Image Analysis, the specialists in objective and sensitive quantification of MRI in immune-inflammatory clinical studies secures investment of over $500,000 from the UK angel investors « Image Analysis [cached]

Other board members include Mark Hinton, Chief Technology Officer and two non-executive directors Dr. André Groenewegen of UCB and Jeremy Nettle of Oracle (investor).

Andre ... [cached]

Andre Groenewegen

Andre Groenewegen - UCB
Andre Groenewegen, Vice President and General Manager, UCB will present a case study of how UCB have created a marketing campaign centred around the customer. He will discuss how they provided more value for the customer and why it was so successful.

Savient Pharmaceuticals, Inc. [cached]

Andre Groenewegen, Senior VP, Managing Director (Rosemont Pharmaceuticals, Ltd.)

Savient Pharmaceuticals, Inc. Investor Relations [cached]

Dr. Andre Groenewegen, Managing Director of Rosemont Pharmaceuticals, Limited, BTG's wholly owned subsidiary in the UK, has been promoted to the additional post of Senior Vice President, Bio-Technology General Corp.Dr. Groenewegen joined the Company in September 2002 when BTG acquired Rosemont.From 1996 through September 2002, he held a number of positions within Akzo Nobel and its various business units, including Vice President, Rosemont Pharmaceuticals Corp., Director, Sales & Marketing, Organon Belgium and Luxembourg, and in the Strategy and Business Development Department of Organon International.Dr. Groenewegen holds a medical degree from the State University of Utrecht, the Netherlands.

Similar Profiles

Other People with this Name

Other people with the name Groenewegen

Elizabeth Groenewegen
BCom, CA

Andrew Groenewegen
Allied Properties REIT

Paul Groenewegen
Alltech Inc

Jef Groenewegen
Granuband BV

Paul Groenewegen
Masterfeeds Inc

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory